Tancredi V, et al. (1992) Tumor necrosis factor al-ters synaptic transmission in rat hippocampal
slices. Neurosci. Lett. 146:176–8.
Bellinger FP, Madamba SG, Campbell IL, Siggins
GR. (1995) Reduced long-term potentiation in the
dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 198:95–8.
Vallieres L, Campbell IL, Gage FH, Sawchenko
PE. (2002) Reduced hippocampal neurogenesis in
adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 22:486–92.
Metz CN, Bucala R. (1997) Role of macrophage
migration inhibitory factor in the regulation of
the immune response. Adv. Immunol. 66:197–223.
Calandra T, et al. (1995) MIF as a glucocorticoidinduced modulator of cytokine production. Na-ture. 377:68–71.
Mitchell RA, Metz CN, Peng T, Bucala R. (1999)
Sustained mitogen-activated protein kinase
(MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor
(MIF). Regulatory role in cell proliferation and
glucocorticoid action. J. Biol. Chem. 274:18100–6.
Hudson JD, et al. (1999) A proinflammatory cy-tokine inhibits p53 tumor suppressor activity.
J. Exp. Med. 190:1375–82.
Mitchell RA, et al. (2002) Macrophage migration
inhibitory factor (MIF) sustains macrophage
proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc.
Natl. Acad. Sci. U. S. A. 99:345–50.
Kleemann R, et al. (2000) Intracellular action of
the cytokine MIF to modulate AP-1 activity and
the cell cycle through Jab1. Nature. 408:211–6.
Bacher M, et al. (1998) MIF expression in the rat
brain: implications for neuronal function. Mol.
Med. 4:217–30.
Matsunaga J, et al. (1999) Enzyme activity of
macrophage migration inhibitory factor toward
oxidized catecholamines. J. Biol. Chem. 274:3268–71.
Oyama R, Yamamoto H, Titani K. (2000) Glutamine synthetase, hemoglobin alpha-chain, and
macrophage migration inhibitory factor binding
to amyloid beta-protein: their identification in rat
brain by a novel affinity chromatography and in
Alzheimer's disease brain by immunoprecipitation. Biochim. Biophys. Acta. 1479:91–102.
Popp J, et al. (2009) Macrophage migration in-hibitory factor in mild cognitive impairment and
Alzheimer's disease. J. Psychiatr. Res. 43:749–53.
Bryan KJ, et al. (2008) Expression of CD74 is in-creased in neurofibrillary tangles in Alzheimer's
disease. Mol. Neurodegener. 3:13.
Sturchler-Pierrat C, et al. (1997) Two amyloid precursor protein transgenic mouse models with
Alzheimer disease-like pathology. Proc. Natl.
Acad. Sci. U. S. A. 94:13287–92.
Lubetsky JB, et al. (2002) The tautomerase active
site of macrophage migration inhibitory factor is
a potential target for discovery of novel antiinflammatory agents. J. Biol. Chem. 277:24976–82.
Kayed R, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:486–9.
